Toronto Cardio-Oncology Network (TCON)
@tocardiooncnet
TCON integrates Toronto’s community of oncologists, cardiologists, and scientists to better alleviate the CVD sequelae faced by cancer patients and survivors
ID: 1706692368634658816
https://forms.gle/oN3hThbze349pFW9A 26-09-2023 15:29:20
81 Tweet
141 Followers
153 Following
Great to see part of my #PhD published. In this #echofirst pilot study we showed that anthracycline therapy impacts coronary physiology. This may help us understand the mechanism anthracycline #cardiotoxicity better. 🙏 to my supervisors Kaz Negishi@Cardiologist/ Heart Mafia & Faraz Pathan. #cardioonc
Today we had the honor to represent CCS in a joint session at SIAC discussing the most relevant updates in Cardio Oncology! Team dineshpmcc Husam Abdel-Qadir Peter Munk Cardiac Centre Thank you Adrian Baranchuk MD FACC FRCPC FCCS FSIAC! Oscar Calvillo Montserrat Carrillo
The house that dineshpmcc built!
You cannot improve cancer outcomes without having a national strategy to deal with cancer therapy related cardiac dysfunction NHS England . Congrats Maria Sol Andres 🇦🇷🇬🇧. So proud and honoured to be a part of this stellar team Royal Brompton and Harefield Guy's and St Thomas' #cardiac #cancer
Enjoyed doing my 1st #cardioonc podcast t.ly/Fdxli with JACC Journals Bonnie Ky dineshpmcc Husam Abdel-Qadir discussing the evidence on 1. #SGLT2i in pts treated with anthracyclines 2. Withdrawal of NHA Therapy in mild #Cancer Therapy-Related Cardiotoxicity #JACCCardioOnc
It's a true honour being part of this amazing team! dineshpmcc Husam Abdel-Qadir Coleen Power Chris Y Inbar Nardi Peter Munk Cardiac Centre University Health Network Canadian Cardiac Oncology Network #cardioonc #Cardiology
Check out our latest in Nature Reviews Cardiology on the cardiovascular impacts by ionizing radiation James WS Jahng, PhD Hyunsoo Joshua No, MD, CMD Stanford CVI Bill Loo MD PhD ⚡️☢️ Stanford Radiation Oncology Cancer Epi & Genetics Greenstone Biosciences. Proud of our team effort went into this comprehensive review! 👉rdcu.be/dNpPJ
A herculean #cardioonc effort amongst experts in assembling this statement on the rapidly evolving landscape of CV toxicities in cancer immunotherapeutics. Great resource to study more of what we don't know! 👏to colleagues and friends European Society of Cardiology Journals doi.org/10.1002/ejhf.3…
Excited to announce our latest #CardioOncology research: "HFA-ICOS score predicts anthracycline-related CV toxicity and all-cause mortality". Congratulations to the CardioTox team! academic.oup.com/eurheartj/adva… EHJ Editor-in-Chief CardioQuironMadrid International Cardio-Oncology Society Borja Rivero Santana Jesús Saldaña García Cardiología La Paz
Proud 2 present this vision for #CardioOnc in Circulation as part of American Heart Association centennial collection! Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation | Circulation ahajournals.org/doi/10.1161/CI…
DEADLINE coming up soon! Make sure to submit your Best #CardioOnc case! International Cardio-Oncology Society American Society of Echocardiography
Don’t miss our next CCON Webinar on Sept 6th at 12pm EST! We will hear from Drs. Anca Prica (Anca Prica) & Barbara Doumouras (Barbara Doumouras) about the cardio-oncology complications of stem cell transplants!🫀🩸 Register here: tinyurl.com/mzh42waf
Inbar Nardi presented some extremely provocative data on the potential mechanisms through which PCSK9I may be valuable in augmenting anti-tumor benefit and reducing #ascvd risk in #ici treated patients Peter Munk Cardiac Centre Ted Rogers Centre for Heart Research